An update on the evidence base for peginterferon β1a in the treatment of relapsing–remitting multiple sclerosis

by Pavan Bhargava, Scott D. Newsome
Published 2016-11-01

Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders

by Yujie Wang, Mohammad S. Sadaghiani, Fan Tian, Kathryn C. Fitzgerald, Lilja Solnes, Scott D. Newsome
Published 2021-09-01

JC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphoma

by Kathryn B. Holroyd, Elias S. Sotirchos, Scott R. DeBoer, Kelly A. Mills, Scott D. Newsome
Published 2017-06-01

Peginterferon beta-1a reduces disability worsening in relapsing–remitting multiple sclerosis: 2-year results from ADVANCE

by Scott D. Newsome, Bernd C. Kieseier, Shifang Liu, Xiaojun You, Elizabeth Kinter, Serena Hung, Bjoern Sperling
Published 2017-01-01

Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial

by Joleen T. White, Scott D. Newsome, Bernd C. Kieseier, Robert A. Bermel, Yue Cui, Ali Seddighzadeh, Serena Hung, Mary Crossman, Meena Subramanyam
Published 2016-07-01

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN

by Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold, Gereon Nelles, Serena Hung, Yue Cui, Shulian Shang, Maria L. Naylor, Marcelo Kremenchutzky
Published 2018-08-01

Unsupervised MR harmonization by learning disentangled representations using information bottleneck theory

by Lianrui Zuo, Blake E. Dewey, Yihao Liu, Yufan He, Scott D. Newsome, Ellen M. Mowry, Susan M. Resnick, Jerry L. Prince, Aaron Carass
Published 2021-11-01

Revisiting brain atrophy and its relationship to disability in multiple sclerosis.

by Navid Shiee, Pierre-Louis Bazin, Kathleen M Zackowski, Sheena K Farrell, Daniel M Harrison, Scott D Newsome, John N Ratchford, Brian S Caffo, Peter A Calabresi, Dzung L Pham, Daniel S Reich
Published 2012-01-01